Personal information

No personal information available

Activities

Collapse all

Employment (1)

University of Minnesota: Minneapolis, Minnesota, US

2003-07 to present | Researcher 5 (Division of Biostatistics, School of Public Health)
Employment
Source: Self-asserted source
Nicole Engen

Education and qualifications (2)

University of Minnesota: Minneapolis, Minnesota, US

2001-09 to 2003-05 | M.S. (Division of Biostatistics, School of Public Health)
Education
Source: Self-asserted source
Nicole Engen

University of Minnesota Morris: Morris, Minnesota, US

1997-09 to 2001-06 | B.S (Mathematics)
Education
Source: Self-asserted source
Nicole Engen

Works (30)

Cerebrospinal Fluid Cytokines and Chemokines Involved in Cytotoxic Cell Function and Risk of Acute 14-Day Mortality in Persons with Advanced HIV and Cryptococcal Meningitis

The Journal of Infectious Diseases
2025-02-20 | Journal article
DOI: 10.1093/infdis/jiae421
Contributors: Elizabeth C Okafor; Liliane Mukaremera; Kathy H Hullsiek; Nicole Engen; Lillian Tugume; Kenneth Ssebambulidde; Abdu K Musubire; Edwin Nuwagira; Edward Mpoza; Darlisha A Williams et al.
Source: check_circle
Crossref

Adjunctive Single-Dose Liposomal Amphotericin to Prevent Cryptococcal Meningitis in People With HIV–Associated Cryptococcal Antigenemia and Low Plasma Cryptococcal Antigen Titers

Clinical Infectious Diseases
2025-02-05 | Journal article
DOI: 10.1093/cid/ciae266
Contributors: David B Meya; Elizabeth Nalintya; Caleb P Skipper; Paul Kirumira; Peruth Ayebare; Rose Naluyima; Teopista Namuli; Fred Turya; Stewart Walukaga; Nicole Engen et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Recurrence of Symptoms Following Cryptococcal Meningitis: Characterizing a Diagnostic Conundrum With Multiple Etiologies

Clinical Infectious Diseases
2023-03-21 | Journal article
DOI: 10.1093/cid/ciac853
Part of ISSN: 1058-4838
Part of ISSN: 1537-6591
Contributors: Nathan Bahr; Caleb P Skipper; Kathy Huppler-Hullsiek; Kenneth Ssebambulidde; Bozena M Morawski; Nicole W Engen; Edwin Nuwagira; Carson M Quinn; Prashanth S Ramachandran; Emily E Evans et al.
Source: Self-asserted source
Nicole Engen

Tixagevimab–cilgavimab for treatment of patients hospitalised with COVID-19: a randomised, double-blind, phase 3 trial

The Lancet Respiratory Medicine
2022-10 | Journal article
DOI: 10.1016/s2213-2600(22)00215-6
Part of ISSN: 2213-2600
Contributors: Thomas L. Holland; Adit A. Ginde; Roger Paredes; Thomas A. Murray; Nicole Engen; Greg Grandits; Andrew Vekstein; Noel Ivey; Ahmad Mourad; Uriel Sandkovsky et al.
Source: Self-asserted source
Nicole Engen

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Annals of Internal Medicine
2022-09 | Journal article
DOI: 10.7326/m22-1503
Part of ISSN: 0003-4819
Part of ISSN: 1539-3704
Contributors: ACTIV-3/TICO Study Group*; Christina Barkauskas; Eleftherios Mylonakis; Garyfallia Poulakou; Barnaby E. Young; David M. Vock; Lianne Siegel; Nicole Engen; Greg Grandits; Nilima R. Mosaly et al.
Source: Self-asserted source
Nicole Engen

Therapeutic Lumbar Punctures in Human Immunodeficiency Virus–Associated Cryptococcal Meningitis: Should Opening Pressure Direct Management?

Open Forum Infectious Diseases
2022-09-02 | Journal article
DOI: 10.1093/ofid/ofac416
Contributors: Enock Kagimu; Nicole Engen; Kenneth Ssebambulidde; John Kasibante; Tadeo K Kiiza; Edward Mpoza; Lillian Tugume; Edwin Nuwagira; Laura Nsangi; Darlisha A Williams et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Efficacy and safety of two neutralising monoclonal antibody therapies, sotrovimab and BRII-196 plus BRII-198, for adults hospitalised with COVID-19 (TICO): a randomised controlled trial

The Lancet Infectious Diseases
2022-05 | Journal article
DOI: 10.1016/s1473-3099(21)00751-9
Part of ISSN: 1473-3099
Contributors: Wesley H. Self; Uriel Sandkovsky; Cavan S. Reilly; David M. Vock; Robert L. Gottlieb; Michael Mack; Kevin Golden; Emma Dishner; Andrew Vekstein; Emily R. Ko et al.
Source: Self-asserted source
Nicole Engen

Feasibility of SARS-CoV-2 Antibody Testing in Remote Outpatient Trials

Open Forum Infectious Diseases
2021-10-06 | Journal article
DOI: 10.1093/ofid/ofab506
Part of ISSN: 2328-8957
Contributors: Sarah M Lofgren; Elizabeth C Okafor; Alanna A Colette; Katelyn A Pastick; Caleb P Skipper; Matthew F Pullen; Melanie R Nicol; Tyler D Bold; Ananta S Bangdiwala; Nicole W Engen et al.
Source: Self-asserted source
Nicole Engen

Hydroxychloroquine as Pre-exposure Prophylaxis for Coronavirus Disease 2019 (COVID-19) in Healthcare Workers: A Randomized Trial

Clinical Infectious Diseases
2021-06-01 | Journal article
DOI: 10.1093/cid/ciaa1571
Part of ISSN: 1058-4838
Part of ISSN: 1537-6591
Contributors: Radha Rajasingham; Ananta S Bangdiwala; Melanie R Nicol; Caleb P Skipper; Katelyn A Pastick; Margaret L Axelrod; Matthew F Pullen; Alanna A Nascene; Darlisha A Williams; Nicole W Engen et al.
Source: Self-asserted source
Nicole Engen

Lessons Learned From Conducting Internet-Based Randomized Clinical Trials During a Global Pandemic

Open Forum Infectious Diseases
2021-02-01 | Journal article
DOI: 10.1093/ofid/ofaa602
Contributors: Matthew F Pullen; Katelyn A Pastick; Darlisha A Williams; Alanna A Nascene; Ananta S Bangdiwala; Elizabeth C Okafor; Katherine Huppler Hullsiek; Caleb P Skipper; Sarah M Lofgren; Nicole Engen et al.
Source: check_circle
Crossref

Baseline Serum C-Reactive Protein Level Predicts Mortality in Cryptococcal Meningitis

Open Forum Infectious Diseases
2020-12-01 | Journal article
DOI: 10.1093/ofid/ofaa530
Contributors: Supavit Chesdachai; Nicole W Engen; Joshua Rhein; Lillian Tugume; Tadeo Kiiza Kandole; Mahsa Abassi; Kenneth Ssebambulidde; John Kasibante; Darlisha A Williams; Caleb P Skipper et al.
Source: check_circle
Crossref

Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19

Annals of Internal Medicine
2020-10-20 | Journal article
DOI: 10.7326/M20-4207
Contributors: Caleb P. Skipper; Katelyn A. Pastick; Nicole W. Engen; Ananta S. Bangdiwala; Mahsa Abassi; Sarah M. Lofgren; Darlisha A. Williams; Elizabeth C. Okafor; Matthew F. Pullen; Melanie R. Nicol et al.
Source: check_circle
Crossref

Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial

Canadian Journal of Anesthesia/Journal canadien d'anesthésie
2020-09 | Journal article
DOI: 10.1007/s12630-020-01684-7
Part of ISSN: 0832-610X
Part of ISSN: 1496-8975
Contributors: Sylvain A. Lother; Mahsa Abassi; Alyssa Agostinis; Ananta S. Bangdiwala; Matthew P. Cheng; Glen Drobot; Nicole Engen; Kathy H. Hullsiek; Lauren E. Kelly; Todd C. Lee et al.
Source: Self-asserted source
Nicole Engen

Phase I EnACT Trial of the Safety and Tolerability of a Novel Oral Formulation of Amphotericin B

Antimicrobial Agents and Chemotherapy
2020-09-21 | Journal article
DOI: 10.1128/aac.00838-20
Part of ISSN: 0066-4804
Part of ISSN: 1098-6596
Contributors: Caleb Skipper; Mucunguzi Atukunda; Anna Stadelman; Nicole W. Engen; Ananta S. Bangdiwala; Katherine H. Hullsiek; Mahsa Abassi; Joshua Rhein; Melanie R. Nicol; Eva Laker et al.
Source: Self-asserted source
Nicole Engen

A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19

New England Journal of Medicine
2020-08-06 | Journal article
DOI: 10.1056/nejmoa2016638
Part of ISSN: 0028-4793
Part of ISSN: 1533-4406
Contributors: David R Boulware; Matthew F. Pullen; Ananta S. Bangdiwala; Katelyn A. Pastick; Sarah M. Lofgren; Elizabeth C. Okafor; Caleb P. Skipper; Alanna A. Nascene; Melanie R Nicol; Mahsa Abassi et al.
Source: Self-asserted source
Nicole Engen

Safety of Hydroxychloroquine among Outpatient Clinical Trial Participants for COVID-19

2020-07-23 | Other
DOI: 10.1101/2020.07.16.20155531
Contributors: Sarah M Lofgren; Melanie R Nicol; Ananta S Bangdiwala; Katelyn A Pastick; Elizabeth C Okafor; Caleb P Skipper; Matthew F Pullen; Nicole W Engen; Mahsa Abassi; Darlisha A Williams et al.
Source: check_circle
Crossref

Symptoms of COVID-19 Outpatients in the United States

Open Forum Infectious Diseases
2020-07-01 | Journal article
DOI: 10.1093/ofid/ofaa271
Contributors: Matthew F Pullen; Caleb P Skipper; Kathy H Hullsiek; Ananta S Bangdiwala; Katelyn A Pastick; Elizabeth C Okafor; Sarah M Lofgren; Radha Rajasingham; Nicole W Engen; Alison Galdys et al.
Source: check_circle
Crossref

A randomized evaluation of on-site monitoring nested in a multinational randomized trial

Clinical Trials
2020-02 | Journal article
DOI: 10.1177/1740774519881616
Contributors: Nicole Wyman Engen; Kathy Huppler Hullsiek; Waldo H Belloso; Elizabeth Finley; Fleur Hudson; Eileen Denning; Catherine Carey; Mary Pearson; Jonathan Kagan
Source: check_circle
Crossref

The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (<scp>START</scp>) bone mineral density substudy

HIV Medicine
2020-01 | Journal article
DOI: 10.1111/hiv.12796
Part of ISSN: 1464-2662
Part of ISSN: 1468-1293
Contributors: Andrew Carr; B Grund; AV Schwartz; A Avihingsanon; S Badal‐Faesen; JI Bernadino; V Estrada; A La Rosa; PWG Mallon; S Pujari et al.
Source: Self-asserted source
Nicole Engen

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

The Lancet Respiratory Medicine
2019-11 | Journal article
DOI: 10.1016/s2213-2600(19)30253-x
Part of ISSN: 2213-2600
Contributors: Richard T Davey; Eduardo Fernández-Cruz; Norman Markowitz; Sarah Pett; Abdel G Babiker; Deborah Wentworth; Surender Khurana; Nicole Engen; Fred Gordin; Mamta K Jain et al.
Source: Self-asserted source
Nicole Engen

Inflammation Associates With Impaired Small Arterial Elasticity Early in HIV Disease

Open Forum Infectious Diseases
2018-06-01 | Journal article
DOI: 10.1093/ofid/ofy117
Part of ISSN: 2328-8957
Contributors: Tess E Peterson; Katherine Huppler Hullsiek; Nicole Wyman Engen; Nagalingeswaran Kumarasamy; Anne-Mette Lebech; Angelike Liappis; Antonios Papadopoulos; Mark N Polizzotto; Pamela J Schreiner; Daniel Duprez et al.
Source: Self-asserted source
Nicole Engen

Immediate Initiation of Antiretroviral Therapy for HIV Infection Accelerates Bone Loss Relative to Deferring Therapy: Findings from the START Bone Mineral Density Substudy, a Randomized Trial

Journal of Bone and Mineral Research
2017-12-01 | Journal article
DOI: 10.1002/jbmr.3183
Part of ISSN: 0884-0431
Part of ISSN: 1523-4681
Contributors: Jennifer F Hoy; Birgit Grund; Mollie Roediger; Ann V Schwartz; John Shepherd; Anchalee Avihingsanon; Sharlaa Badal-Faesen; Stephane de Wit; Simone Jacoby; Alberto La Rosa et al.
Source: Self-asserted source
Nicole Engen

Improved quality of life with immediate versus deferred initiation of antiretroviral therapy in early asymptomatic HIV infection.

AIDS (London, England)
2017-04-01 | Journal article
DOI: 10.1097/qad.0000000000001417
PMID: 28121710
PMC: PMC5373969
Contributors: Lifson AR; Grund B; Edward Gardner; Richard Kaplan; Eileen Denning; Engen N; Carey CL; Chen F; Dao S; Eric Florence et al.
Source: Self-asserted source
Nicole Engen

Early Antiretroviral Therapy at High CD4 Counts Does Not Improve Arterial Elasticity: A Substudy of the Strategic Timing of AntiRetroviral Treatment (START) Trial.

Open forum infectious diseases
2016-10-08 | Journal article
DOI: 10.1093/ofid/ofw213
PMID: 27942541
PMC: PMC5144656
Contributors: Baker JV; Hullsiek KH; Engen NW; Nelson R; Chetchotisakd P; Gerstoft J; Jessen H; Losso M; Markowitz N; Munderi P et al.
Source: Self-asserted source
Nicole Engen

INSIGHT FLU005: An Anti-Influenza Virus Hyperimmune Intravenous Immunoglobulin Pilot Study.

The Journal of infectious diseases
2015-09-15 | Journal article
DOI: 10.1093/infdis/jiv453
PMID: 26374911
PMC: PMC4721910
Contributors: INSIGHT FLU005 IVIG Pilot Study Group
Source: Self-asserted source
Nicole Engen

Challenges, successes and patterns of enrolment in the <scp>INSIGHT S</scp>trategic <scp>T</scp>iming of <scp>AntiRetroviral T</scp>reatment (<scp>START</scp>) trial

HIV Medicine
2015-04 | Journal article
DOI: 10.1111/hiv.12229
Part of ISSN: 1464-2662
Part of ISSN: 1468-1293
Contributors: J Grarup; C Rappoport; NW Engen; C Carey; F Hudson; E Denning; S Sharma; E Florence; MJ Vjecha; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group
Source: Self-asserted source
Nicole Engen

Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.

HIV medicine
2015-04-01 | Journal article
DOI: 10.1111/hiv.12239
PMID: 25711329
PMC: PMC4341954
Contributors: Baker JV; Engen NW; Huppler Hullsiek K; Christoph Stephan; Mamta K. Jain; Munderi P; Pett S; Duprez D; International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group
Source: Self-asserted source
Nicole Engen

Investigating the Efficacy of Clinical Trial Monitoring Strategies: Design and Implementation of the Cluster Randomized START Monitoring Substudy

Therapeutic Innovation &amp; Regulatory Science
2015-03 | Journal article
DOI: 10.1177/2168479014555912
Part of ISSN: 2168-4790
Part of ISSN: 2168-4804
Contributors: INSIGHT START Monitoring Substudy Group; Katherine Huppler Hullsiek; Jonathan M. Kagan; Nicole Engen; Jesper Grarup; Fleur Hudson; Eileen T. Denning; Catherine Carey; David Courtney-Rodgers; Elizabeth B. Finley et al.
Source: Self-asserted source
Nicole Engen

HIV replication capacity is an independent predictor of disease progression in persons with untreated chronic HIV infection.

Journal of acquired immune deficiency syndromes (1999)
2010-04-01 | Journal article
DOI: 10.1097/qai.0b013e3181cae480
PMID: 20032783
PMC: PMC2837106
Contributors: Matthew Goetz; Leduc R; Wyman N; Kostman JR; Labriola AM; Lie Y; Weidler J; Coakley E; Bates M; Luskin-Hawk R et al.
Source: Self-asserted source
Nicole Engen

Effects of intermittent IL-2 alone or with peri-cycle antiretroviral therapy in early HIV infection: the STALWART study.

PloS one
2010-02-23 | Journal article
DOI: 10.1371/journal.pone.0009334
PMID: 20186278
PMC: PMC2826395
Contributors: Tavel JA; INSIGHT STALWART Study Group; Babiker A; Fox L; Gey D; Lopardo G; Markowitz N; Paton N; Wentworth D; Wyman N
Source: Self-asserted source
Nicole Engen
How many people are using ORCID?